Abstract Submission Information

Abstract Submission Information

We’re pleased to announce that our theme for the CSAM-SCMA 2022 Scientific Conference is What’s Next: The Future of Addiction Medicine in Canada, and we welcome presentation proposals on this and all other aspects of addiction medicine. The purpose of the conference is to showcase new scientific research and best practices in addiction medicine. Sessions will engage conference attendees, encourage the sharing of diverse perspectives, and build community within the field.

This year we are planning an in-person conference in Saskatoon, Saskatchewan, November 3-5, 2022. Many of the presentations will also be available for on-demand viewing following the in-person event to make our conference accessible to as many people as possible.

We encourage students, researchers, educators, clinicians and health care professionals from diverse organizations and fields to submit abstracts. We especially look forward to submissions from people with lived and living experience of substance use and their families and friends (LLEAFF). You do not need to be a member of CSAM-SMCA to submit an abstract.

Submission Deadline is May 30.

At this time we are planning on an in-person conference and a virtual on-demand conference available after the in-person event. Please read the instructions for each abstract type carefully, as authors may be required to present in person in Saskatoon AND pre-record their presentation for the on-demand event. If restrictions due to the pandemic change, we may revise these plans.

Symposium

A symposium is a 90 to 120-minute session designed to give conference attendees an in-depth understanding of a specific clinical or scientific topic. Symposia should include between three and six related presentations. A complete submission needs to include a “Symposium Overview,” abstract and a separate abstract for EACH presentation in the symposium. List the title of the Symposium Overview for EACH abstract submitted as part of the symposium. A symposium must allocate 25 percent of the session time to questions and answers, as required in CME guidelines. Symposia will be presented in person in Saskatoon, and authors will be invited to pre-record their presentations for the on-demand event.

Workshop

A workshop is a 60 or 90-minute session intended to give attendees an in-depth understanding of a focused topic. Workshop presenters are encouraged to use interactive and experiential teaching formats such as small group discussions, case examples, demonstrations, interactive polls and other skill-building exercises, and these should be described in the abstract. The number of participants in each workshop will be limited to facilitate skill-building and active participation by attendees. Authors of workshops MAY be invited to provide a pre-recorded presentation for the on-demand event.

Oral Presentation

Oral presentations are concise presentations about a research project, new clinical program, educational initiative or other project in addiction medicine. Lead authors will have 12 minutes to describe their project accompanied by visual aids (slides), followed by three minutes of questions. Abstracts will be grouped together and delivered in moderated Oral Presentation Sessions. These will be in-person presentations, delivered live during the conference. Authors of abstracts selected for oral presentation at the conference will also be invited to submit a pre-recorded video for the on-demand conference materials. Please note that a project or report may only be submitted for one type of presentation: oral, poster or digital poster.

Poster Presentation

We will be holding our poster session on Thursday, November 3, in the afternoon. A poster is a visual summary of a research project, new clinical program, educational initiative, or other project or proposal in the field of addiction medicine. Lead Authors will prepare a printed poster to be mounted and displayed during the poster session, describing the project (we suggest organizing the poster with Introduction, Methods, Results and Conclusions, although other written formats are acceptable). Lead authors are expected to attend the poster session in person to discuss their work with conference attendees. Bulletin board size for each poster will be approximately 4 x 4 feet (approximately 1.2 x 1.2m) and mounting materials will be provided. Lead Authors of Poster Presentations may also share their poster in the virtual conference, either by sharing the poster in digital form, or by providing a pre-recorded five-minute video describing the project for on-demand viewing. Posters by trainees will be evaluated, with an award for the Best Poster by a Trainee. Please note that a project or report may only be submitted for one type of presentation: oral, poster or digital poster.

Digital Poster Presentation

Digital Posters will be available in the conference app for on-demand viewing. Digital posters will consist of a pre-recorded video describing a research project, new clinical program, educational initiative or another aspect of addictions. Videos have a limit of five minutes and 12 slides. Lead authors of digital posters will be able to use the asynchronous messaging system in the conference app to respond to questions about their project from other conference attendees. Please note that a project or report may only be submitted for one type of presentation: oral, poster or digital poster.

New: TED-Style Talk

A TED-Style Talk is an opportunity to present great, well-formed ideas in under 18 minutes, followed by 5 minutes of questions. TED-Style talks are focused on the power of ideas to change lives and, ultimately, the world. These talks are generally delivered without notes, although we will allow presenters to have some basic outline notes on cards or a computer during their presentation. These are NOT spontaneous presentations, they are scripted and carefully rehearsed! Powerpoint slides are limited to only absolutely essential illustrations, traditional slides that summarize content are not allowed. All PowerPoint presentations for TED-Style talks must be submitted by September 15th in final format. TED-Style talks focus on you and your presentation — the slides only complement your ideas, they do not repeat your words.

  • TED-Style talks are personal. The only reason to give a TED talk is that you feel passionate about something, and your sense of purpose creates an energy boost for both you and your audience.
  • TED-Style talks often take us on a journey. As the speaker shares their transition from ignorance to understanding of some important truth, we follow along in their footsteps.
  • TED-Style talks are concise. With only 18 minutes, speakers need to cut out any extraneous ideas so that every word counts.

The abstract for a TED-Style talk should be a SUMMARY of your presentation, not a description of what you plan to talk about. TED-Style talks will be recorded live at the conference for the on-demand event.

New: Storytelling Talk

Stories are an important way to share wisdom and build community. New this year will be a storytelling session. Tell us about a person, event, journey or experience related to addiction to share insights and build understanding. Authors of abstracts selected for this session will have 10 minutes to tell us a story. No audiovisual aids are allowed, and memorizing your story is encouraged. Storytellers will be invited to submit a prerecorded video for the on-demand event.

Please review the submission instructions below carefully.

  • Only the author intending to present the material (the lead author) should submit an abstract.
  • Abstracts on all aspects of addiction are welcome. Abstracts that reflect the theme of the conference — What’s Next: The Future of Addiction Medicine in Canada — are encouraged.
  • The objectives for the abstracts at the conference are to:
    • present new scientific research;
    • present best practices in addiction medicine;
    • promote evidence-based treatments, care and interventions;
    • present original, new work based on the latest evidence and data;
    • encourage sharing of diverse perspectives;
    • engage and build community.
  • Abstracts will be evaluated by members of the Scientific Conference Committee. Decisions of the Scientific Conference Committee are final.
  • Only complete abstracts can be considered. Please ensure all details are correct before submitting an abstract.
    • Abstract Body: The abstract should be a maximum of 300 words. Abstracts about research should include the objective, methods, results and conclusions. Abstracts need to concisely describe the project, presentation or workshop proposed.
    • Key Words: Please choose up to 5 from the list (available in the submission portal)
    • Learning Objectives: Each abstract must include two learning objectives that describe what attendees should know or be able to do at the end of the presentation.
    • References: Please list two scientific reports/publications or other sources of information that provide research or background information for your abstract
  • Please use non-stigmatizing language, generic pharmaceutical names, and a minimum of abbreviations.
  • Abstracts can be submitted in English or French. Abstracts must present material in a clear manner with grammar and spelling of a quality suitable for publication.
  • Abstracts and presentations must be free of commercial bias and cannot be used to advertise or advocate for a specific commercial interest.
  • Correspondence will only be with the lead author, who must notify any co-authors. The Scientific Conference Committee is not responsible for notification emails not received due to incorrect contact information.

We look forward to receiving your submission!